These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29385383)

  • 21. The drug quality and security act: how will it change pharmacy?
    Soukup BJ
    Consult Pharm; 2014; 29(5):352. PubMed ID: 25203978
    [No Abstract]   [Full Text] [Related]  

  • 22. Compounding pharmacies: who is in charge?
    Pergolizzi JV; Labhsetwar S; LeQuang JA
    Pain Pract; 2013 Mar; 13(3):253-7. PubMed ID: 23350709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Legislative/Regulatory Update FROM THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS: APPROPRIATIONS.
    McCrory G
    Int J Pharm Compd; 2016; 20(2):95-6. PubMed ID: 27323420
    [No Abstract]   [Full Text] [Related]  

  • 24. Analytic Methods Used in Quality Control in a Compounding Pharmacy.
    Allen LV
    Int J Pharm Compd; 2017; 21(1):31-37. PubMed ID: 28346196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Food and Drug Administration's Misguided Veterinary Guidance.
    Miller DG
    Int J Pharm Compd; 2015; 19(6):449-50. PubMed ID: 26891558
    [No Abstract]   [Full Text] [Related]  

  • 26. Introduction to Quality Control in a Compounding Pharmacy.
    Allen LV
    Int J Pharm Compd; 2016; 20(6):481-484. PubMed ID: 28339387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NABP to inspect compounding pharmacies.
    Traynor K
    Am J Health Syst Pharm; 2013 Jan; 70(2):88-90. PubMed ID: 23292258
    [No Abstract]   [Full Text] [Related]  

  • 29. PreScription: 2017--Some Good Things Happened and Some Others.
    Allen LV
    Int J Pharm Compd; 2018; 22(1):4. PubMed ID: 29385380
    [No Abstract]   [Full Text] [Related]  

  • 30. Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies.
    Pritchett J; McCrory G; Kraemer C; Jensen B; Allen LV
    Int J Pharm Compd; 2018; 22(1):7-16. PubMed ID: 29385381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From the Food and Drug Administration.
    Crawford LM
    JAMA; 2002 Oct; 288(13):1579. PubMed ID: 12350176
    [No Abstract]   [Full Text] [Related]  

  • 32. International Academy of Compounding Pharmacists Legislative/Regulatory Update.
    Rice B
    Int J Pharm Compd; 2017; 21(3):212-213. PubMed ID: 28557782
    [No Abstract]   [Full Text] [Related]  

  • 33. Dilemmas in compounding for the veterinary teaching hospital.
    Kemp DT
    J Am Vet Med Assoc; 1994 Jul; 205(2):263-7. PubMed ID: 7928595
    [No Abstract]   [Full Text] [Related]  

  • 34. How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreak.
    Teshome BF; Reveles KR; Lee GC; Ryan L; Frei CR
    J Am Pharm Assoc (2003); 2014; 54(4):441-5. PubMed ID: 25063265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. President signs compounding law.
    Traynor K
    Am J Health Syst Pharm; 2014 Jan; 71(1):7. PubMed ID: 24352171
    [No Abstract]   [Full Text] [Related]  

  • 36. Final guidance for pharmacy compounding of human drug products under Section 503A.
    Blankenship CE
    Int J Pharm Compd; 2014; 18(5):379-80. PubMed ID: 25577886
    [No Abstract]   [Full Text] [Related]  

  • 37. Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines.
    Allen LV
    Int J Pharm Compd; 2016; 20(4):351. PubMed ID: 28333682
    [No Abstract]   [Full Text] [Related]  

  • 38. Compounding pharmacies: before and after an inspection.
    Kulkarni D; Ricketts S
    Int J Pharm Compd; 2013; 17(5):358-62. PubMed ID: 24459779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compounding pharmacies: friend or foe.
    Springer R
    Plast Surg Nurs; 2013; 33(1):24-8. PubMed ID: 23446505
    [No Abstract]   [Full Text] [Related]  

  • 40. Explanations and unresolved issues pertaining to the development of the Nuclear Pharmacy Compounding Guidelines.
    Hung JC; Augustine SC; Cheng KT; Green RL; Hopkins WM; Laven DL; Nelson BR; Petry NA; Ponto JA; Quinton TM; Swanson DP
    J Am Pharm Assoc (Wash); 2002; 42(5):789-98. PubMed ID: 12269713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.